![]() |
市场调查报告书
商品编码
1954610
全球便携式超音波市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Handheld Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球便携式超音波市场规模为3.9729亿美元,预计将从2026年的4.4828亿美元成长至2034年的11.3143亿美元,在预测期(2026-2034年)内年复合成长率高达12.27%。2025年,北美以41.07%的市场占有率领先,显着反映了即时诊断技术的广泛应用。
便携式超音波设备是紧凑便携的成像诊断系统,可连接到智慧型手机、平板电脑或专用控制台。这些设备能够帮助医院、急诊室、门诊部甚至家庭医疗保健机构快速做出诊断决策。
市场概览
心血管疾病、癌症和泌尿系统疾病等急性和慢性疾病的增加是推动市场成长的主要因素。根据世界卫生组织(WHO)统计,2022年全球新增癌症病例2000万例,这清楚地表明人们对早期且易于获取的诊断成像解决方案的需求日益成长。
此外,人口老化加剧也是推动需求成长的因素。根据美国人口与人口统计研究所统计,2022年美国 65 岁及以上人口为 5,800万,预计到2050年将达到 8,200万。随着人口老化,慢性疾病的风险增加,因此对便携式且经济高效的影像工具的需求也随之增加。
市场动态
市场驱动因素
慢性病和急性病病例增加
心血管疾病的增加显着推动了便携式超音波设备的普及。根据美国疾病管制与预防中心(CDC)(2024)统计,美国每年约有 80.5万例心臟病发作。便携式超音波系统的便携性和即时影像功能使其成为急诊和重症监护环境下心臟评估的理想选择。
此外,人们对早期诊断重要性以及床边超音波(POCUS)益处的认识不断提高,加速全球对便携式超音波产品的需求。
市场限制因子
先进设备成本高
儘管便携式超音波设备便携,但价格仍然昂贵。例如,根据 DRSONO2024年发布的资料,Tri-scan Max 设备的价格约为 3,599 美元。由于技术整合导致的高昂製造成本限制了其普及,尤其是在发展中国家。
此外,再生便携式超音波扫描仪的价格更低。根据福斯科技股份有限公司2025年的资料,翻新的in-A5I手持式扫描仪的价格在1600美元至1800美元之间,这可能会降低对新系统的需求。
市场机会
新兴经济体医疗基础设施的改善
中国、印度和巴西等国医疗支出的成长创造新的成长机会。根据美国国际贸易管理局(ITA)2023年的资料,巴西医疗保健支出占其 GDP 的9.47%。
新兴经济体基础设施的改善和研发投入的增加扩大先进成像系统的普及范围,预计市场规模将从2026年的4.4828亿美元进一步成长到2034年的11.3143亿美元。
市场挑战
监管和合规障碍
美国食品药物管理局(FDA)和欧盟等机构的严格监管给製造商带来了审批方面的挑战。合规要求、设备安全标准和偿付限制可能会延迟产品商业化。
市场趋势
人工智慧(AI)整合
技术进步是塑造市场的主要趋势。人工智慧和机器学习的整合提高了诊断准确性,实现了测量自动化,并提升了工作流程效率。
例如,2024年4月,GE医疗推出了整合CaptionAI软体的Vscan Air SL手持式系统,可实现快速心臟评估。此类创新拓展临床应用领域,包括放射学、心臟病学、妇科和肌肉骨骼影像学。
其他值得关注的趋势包括:
依转换器类型
市场细分为线阵、相控阵和其他类型。
依应用领域
应用领域包括放射科、妇科、心臟科和泌尿科。
依最终使用者划分
最终使用者包括医院、专科诊所和影像诊断中心。
北美
北美将持续引领市场,2025年市场规模达到1.6315亿美元。这一成长主要得益于美国人均医疗保健支出达到14,570美元(CMS2023)。
欧洲
由于人口老化加剧,预计欧洲市场将保持稳定成长。根据Centre for Ageing Better的资料,英国有超过1,000万人年龄在65岁及以上。
亚太地区
预计亚太地区的成长率最高。根据美国国家生物技术资讯中心(NCBI,2023)的资料,中国约有 3.3亿人患有心血管疾病,对诊断的需求不断成长。
拉丁美洲、中东和非洲
由于医疗基础设施的扩张,这些地区的市场成长。巴西拥有约 7,191 家医院(ITA,2023),这为诊断影像设备的引进提供了支援。
The global handheld ultrasound market was valued at USD 397.29 million in 2025 and is projected to grow from USD 448.28 million in 2026 to USD 1,131.43 million by 2034, registering a strong CAGR of 12.27% during the forecast period (2026-2034). In 2025, North America dominated the market with a 41.07% share, reflecting strong adoption of point-of-care diagnostic technologies.
Handheld ultrasound devices are compact, portable imaging systems that connect to smartphones, tablets, or dedicated consoles. These devices enable rapid diagnostic decisions in hospitals, emergency settings, ambulatory care, and even home healthcare environments.
Market Overview
The increasing prevalence of acute and chronic disorders such as cardiovascular diseases, cancer, and urological conditions is a major growth driver. According to the World Health Organization (WHO), 20.0 million new cancer cases were reported globally in 2022, highlighting the growing demand for early and accessible diagnostic imaging solutions.
Additionally, the rising geriatric population is fueling demand. The U.S. Population Reference Bureau reported that 58.0 million Americans were aged 65 and above in 2022, a figure projected to reach 82 million by 2050. Aging populations are more susceptible to chronic illnesses, increasing the need for portable and cost-effective imaging tools.
Market Dynamics
Market Drivers
Rising Prevalence of Chronic and Acute Diseases
The growing burden of cardiovascular diseases significantly contributes to handheld ultrasound adoption. According to the CDC (2024), approximately 805,000 heart attacks occur annually in the U.S. The portability and real-time imaging capability of handheld systems make them highly suitable for cardiac assessments in emergency and intensive care settings.
Furthermore, growing awareness regarding early diagnosis and the benefits of point-of-care ultrasound (POCUS) are accelerating product demand globally.
Market Restraints
High Cost of Advanced Devices
Despite their portability, advanced handheld ultrasound devices remain expensive. For example, according to 2024 data published by DRSONO, the price of the Tri-scan Max device is approximately USD 3,599.0. High manufacturing costs due to technological integration limit adoption, particularly in developing countries.
Additionally, refurbished handheld ultrasound scanners are available at lower prices. As per 2025 data from Focus Technology Co., Ltd., refurbished in-A5I handheld scanners range between USD 1,600.0 and USD 1,800.0, which may reduce demand for new systems.
Market Opportunities
Improving Healthcare Infrastructure in Emerging Economies
Rising healthcare expenditure in countries such as China, India, and Brazil is creating new growth opportunities. According to the International Trade Administration (ITA) 2023 data, healthcare spending accounts for 9.47% of Brazil's GDP.
Improving infrastructure and growing R&D investments in emerging economies are expanding access to advanced imaging systems, further driving market growth from USD 448.28 million in 2026 to USD 1,131.43 million by 2034.
Market Challenges
Regulatory and Compliance Barriers
Stringent regulations from authorities such as the FDA and the European Union create approval challenges for manufacturers. Compliance requirements, device security standards, and reimbursement limitations can delay product commercialization.
Market Trends
Integration of Artificial Intelligence (AI)
Technological advancements are a key trend shaping the market. AI and machine learning integration enhance diagnostic accuracy, automate measurements, and improve workflow efficiency.
For instance, in April 2024, GE Healthcare launched CaptionAI software integrated into its Vscan Air SL handheld system to enable rapid cardiac assessments. Such innovations are expanding clinical applications across radiology, cardiology, gynecology, and musculoskeletal imaging.
Other notable trends include:
By Transducer Type
The market is segmented into linear, phased array, and others.
By Application
Applications include radiology, gynecology, cardiology, urology, and others.
By End User
End users include hospitals, specialty clinics, diagnostic imaging centers, and others.
North America
North America generated USD 163.15 million in 2025, maintaining market leadership. Growth is supported by high per capita healthcare expenditure, which reached USD 14,570.0 in the U.S. (CMS 2023).
Europe
Europe is expected to grow steadily due to rising geriatric populations. According to 2025 data from the Centre for Ageing Better, over 10 million people aged 65+ live in the U.K.
Asia Pacific
Asia Pacific is projected to witness the highest growth rate. According to NCBI (2023), approximately 330 million individuals in China suffer from cardiovascular diseases, increasing diagnostic demand.
Latin America & Middle East & Africa
These regions are growing due to healthcare infrastructure expansion. Brazil has approximately 7,191 hospitals (ITA 2023), supporting imaging adoption.
Competitive Landscape
The market is semi-consolidated with key players such as GE Healthcare, Philips, Butterfly Network, Shenzhen Mindray, Clarius, and Konica Minolta. Companies focus on AI integration, wireless technology, and product launches to strengthen their market positions.
Recent developments include:
Conclusion
The global handheld ultrasound market is set for significant expansion, increasing from USD 397.29 million in 2025 to USD 1,131.43 million by 2034. Growth is driven by rising chronic disease prevalence, increasing geriatric populations, AI-driven technological advancements, and expanding healthcare infrastructure in emerging markets. Although high device costs and regulatory complexities present challenges, strong innovation and growing point-of-care adoption are expected to sustain long-term market growth worldwide.
Segmentation By Transducer Type
By Application
By End User
By Region